Closing the Knowledge Gap: Hepatitis B Reactivation in Immunosuppression

Abstract

Background The usage of immunosuppressive medications (ISMs), and specifically disease-modifying antirheumatic drugs (DMARDs), in a wide range of internal medicine subspecialties, has increased the risk of hepatitis B virus reactivation (HBVr). We assessed the understanding of HBVr using a Canada-wide survey. C a n a d i a n J o u r n a l o f G e n e r a l I n t e r n a l M e d i c i n e 18 V o l u m e 1 4 , I s s u e 2 , 2 0 1 9 O r i g i n a l A r t i c l e